Filtyp
LP3 attended the 28th Swedish Conference on Macromolecular Structure & Function (SWEPROT) in Tällberg last weekend and presented our capabilities through several posters. Several PPS team members visited the meeting with around 130 other participants from the Swedish protein science community.More info on SWEPROT is found on the homepage (external).
https://www.lp3.lu.se/article/lp3-tallberg-conference-2025 - 2026-04-21
Several LP3 members presented our capabilities with a poster at the first conference held in Linxs new facilities. The conference was held to celebrate the opening of the LINXS at Brunnshög in the newly build Loop (more info here on Linxs homepage). Several staff members of PPS visited the opening with many national and international participants interested in X-ray and neutron applications.
https://www.lp3.lu.se/article/lp3-inagural-conference-new-linxs - 2026-04-21
More than a hundred participants from all over Europe attended the three-day program with workshops, lectures and vendor presence to share knowledge in the field of protein production and purification. The P4EU (Protein Production and Purification Partnership in Europe; see external homepage) is a professional network, whose members engage in various aspects of protein expression, purification and
https://www.lp3.lu.se/article/lp3-staff-co-organised-21st-p4eu-meeting-gothenburg-sweden-25-27th-august-2025 - 2026-04-21
The distributed national research infrastructure Protein Production Sweden (PPS), where LP3 is included, met for its fourth annual staff retreat at LINXS in Lund. The 27 staff researchers of PPS attending used the three-day meeting to discuss and reflect on the first 3.5 years of PPS operations delivering more than 1000 protein batches so far, present new method developments in PPS and plan furthe
https://www.lp3.lu.se/article/lp3-organized-fourth-pps-staff-retreat-lund - 2026-04-21
LP3 again extends its portfolio of available machines by welcoming the Monolith X (Nanotemper). Thanks to infrastructure grants from LU, the faculties of Science and Medicine, we can now make the latest MicroScale Thermophoresis (MST) and Spectral Shift (SpS) equipment available to users.The Monolith X allows in-depth interaction and binding studies between a labeled target and a ligand, for examp
https://www.lp3.lu.se/article/new-lp3-equipment-solution-binding-affinity-studies-now-accessible - 2026-04-21
Posters on LP3 and PPS facilities were represented at the 37th MAX IV User Meeting (external website) by our research engineer Victoriia Murina. The meeting was attended by over 450 participants and celebrated two significant milestones for MAX laboratory – ten years since the first beamline became operational at MAX IV and 40 years of scientific activity.
https://www.lp3.lu.se/article/lp3-and-pps-presented-37th-maxiv-user-meeting - 2026-04-21
Friday the 6th of March marked the kick-off of the new LINXS theme Pandemics and Alertness (PandA), in which LP3 participates. Understanding and mitigating large-scale viral outbreaks is one of the most pressing global challenges of our time. PandA brings together virologists and experts in X-ray, neutron, and complementary techniques to explore viral structures, interactions, and dynamics. By str
https://www.lp3.lu.se/article/kick-linxs-theme-pandemic-and-alertness-panda - 2026-04-21
An international collaboration between the Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform, has initiated biophysical and structural studies of three non-structural proteins from the novel coronavirus, SARS CoV-2, the causative agent of COVID-19. Recently we managed to solve the structure of one of these proteins, Nsp10, by using the BioMAX be
https://www.lp3.lu.se/article/collaborative-research-project-corona-virus-proteins - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. Results from the collaborative corona virus protein research project involvning Lund Protein Production Platform (LP3), the UCL School of Pharmacy and ESS, through its DEMAX platform have been published in the International Journal of Molecular Sciences.
https://www.lp3.lu.se/article/results-collaborative-corona-virus-protein-research-project-published - 2026-04-21
LP3 activities will be limited during the summer, especially in July and early August. In the meantime, here’s some recommended summer reading: https://www.lp3.lu.se/article/recommended-summer-reading - 2026-04-21
FragMAX, a project run in collaboration between LP3, MAXIV, Astra Zeneca and SARomics Biostructures, has been awarded funding from the Swedish Research Council. The project aims to establish a fragment based screening facility, enabling scientists and small companies to screen low molecular weight fragments for binding to target proteins using X-ray crystallography.Read more about the FragMAX proj
https://www.lp3.lu.se/article/fragmax-awarded-funding-swedish-research-council - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. LP3 was successful in its application for renewal of beamtime access at BioMAX (the X-ray macromolecular crystallography beamline of MAX IV). The protein structure pipeline at LP3 is now established. Users can get their protein samples crystallised and the resulting crystals can on a regular basis be evaluated for dif
https://www.lp3.lu.se/article/renewal-beamtime-access-biomax-and-allocated-time-scilifelab-cryo-em-facility - 2026-04-21
A team from the Lund Protein Production Platform, Karolinska Institute, and the European Spallation Source have published an optimised approach to high-yield protein deuteration at low cost, for neutron protein crystallography in Archives of Biochemistry and Biophysics (external website).
https://www.lp3.lu.se/article/more-less-low-cost-high-yield-protein-deuteration-neutron-crystallography - 2026-04-21
The baculovirus-insect cell expression system has become one of the most widely used eukaryotic expression systems for heterologous protein production in many laboratories. To date, limited data has been presented in the literature to benchmark the protocols used for baculovirus vectors, and this study facilitates the selection of a system for optimal production of target proteins. The benchmarkin
https://www.lp3.lu.se/article/baculovirus-driven-protein-expression-insect-cells-benchmarking-study - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. LP3 has been granted beamtime at the X-ray macromolecular crystallography beamline of MAX IV, BioMAX. This allows users to have their crystals rapidly evaluated for diffraction. With funding from BioCARE (a governmental supported strategic research area in cancer (external website)) the Lund Protein Production Platfor
https://www.lp3.lu.se/article/beamtime-biomax - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. The Lund Protein Production Platform is one of several protein production facilities in Sweden that form the Protein Production Network Sweden (PPNS), each with its own specialties and focus. PPNS is an informal network formed in 2013 between protein production facilities at Swedish universities. The overall aim is to
https://www.lp3.lu.se/article/protein-production-network-sweden-launches-new-website - 2026-04-21
The DEuteration and MAcromolecular Xtallisation (DEMAX) platform of the European Spallation Source ERIC (ESS) moved into Biology House A at Lund University and is now co-localised with the Lund Protein Production Platform (LP3). DEMAX (external website) and LP3 are collaborating to coordinate their efforts to develop cost-effective production of deuterated biomaterials (lipids and proteins) for ne
https://www.lp3.lu.se/article/partnership-between-lp3-and-demax - 2026-04-21
A Bioscreen C system for microbiological growth studies is now available at LP3. The Bioscreen C (external website) can incubate, shake, and measure the turbidity (OD) of up to 200 samples simultaneously.
https://www.lp3.lu.se/article/new-system-microbiological-growth-monitoring - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. LP3 is part of the Protein Production Network Sweden (PPNS) that aims to make multiple protein expression hosts, methodologies and competence in protein production available to the Swedish academic life science community. Collaboration between Swedish protein production sites is crucial in order to solve complex scien
https://www.lp3.lu.se/article/protein-production-network-sweden-pilot-expression-screen-completed - 2026-04-21
This article is over 5 years old, and the information may therefore be outdated. LP3 is taking part in the formation of a network of Swedish protein production facilities together with Protein Science Facility at Karolinska Institutet/SciLifeLab (external website) Mammalian Protein Expression at Göteborg University (external website) Protein Expertise Platform at Umeå University (external website)
https://www.lp3.lu.se/article/network-swedish-protein-production-facilities - 2026-04-21
